摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(4-甲氧基苯甲酰基)苯甲腈 | 60694-67-9

中文名称
3-(4-甲氧基苯甲酰基)苯甲腈
中文别名
——
英文名称
3-Cyano-4'-methoxy-benzophenon
英文别名
3-cyano-4'-methoxybenzophenone;3-(4-methoxybenzoyl)benzonitrile
3-(4-甲氧基苯甲酰基)苯甲腈化学式
CAS
60694-67-9
化学式
C15H11NO2
mdl
——
分子量
237.258
InChiKey
CWEXKDRORMHULO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    50.1
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2926909090

SDS

SDS:46740966ab6fdf2a629d911d6dd035d6
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-(4-甲氧基苯甲酰基)苯甲腈二异丁基氢化铝 作用下, 以 四氢呋喃甲苯 为溶剂, 反应 2.0h, 生成
    参考文献:
    名称:
    Synthesis and structure–activity relationships of benzophenone-bearing diketopiperazine-type anti-microtubule agents
    摘要:
    KPU-105 (4), a potent anti-microtubule agent that contains a benzophenone was derived from the dike-topiperazine-type vascular disrupting agent (VDA) plinabulin 3, which displays colchicine-like tubulin depolymerization activity. To develop derivatives with more potent anti-microtubule and cytotoxic activities, we further modified the benzophenone moiety of 4. Accordingly, we obtained a 4-fluorobenzophenone derivative 16j that inhibited tumor cell growth in vitro with a subnanomolar IC50 value against HT-29 cells (IC50 = 0.5 nM). Next, the effect of 16j on mitotic spindles was evaluated in HeLa cells. Treatment with 3 nM of 16j partially disrupted the interphase microtubule network. By contrast, treatment with the same concentration of CA-4 barely affected the microtubule network, indicating that 16j exhibited more potent anti-mitotic effects than did CA-4. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.05.059
  • 作为产物:
    描述:
    3-氰基苯甲酰氯三氯化铝 盐酸 作用下, 以 (2S)-N-methyl-1-phenylpropan-2-amine hydrate 、 二氯甲烷乙酸乙酯苯甲醚 为溶剂, 生成 3-(4-甲氧基苯甲酰基)苯甲腈
    参考文献:
    名称:
    Leukotriene antagonists and use thereas
    摘要:
    这项发明提供了苯乙烯衍生物,这些衍生物是白三烯拮抗剂,以及这些衍生物的配方,以及使用这些衍生物治疗由白三烯过度释放引起的疾病的方法。
    公开号:
    US04853398A1
点击查看最新优质反应信息

文献信息

  • Synthesis of biaryl ketones by arylation of Weinreb amides with functionalized Grignard reagents under thermodynamic control <i>vs.</i> kinetic control of <i>N</i>,<i>N</i>-Boc<sub>2</sub>-amides
    作者:Guangchen Li、Michal Szostak
    DOI:10.1039/d0ob00813c
    日期:——
    A highly efficient method for chemoselective synthesis of biaryl ketones by arylation of Weinreb amides (N-methoxy-N-methylamides) with functionalized Grignard reagents is reported. This protocol offers rapid entry to functionalized biaryl ketones after Mg/halide exchange with i-PrMgCl·LiCl under operationally-simple and practical reaction conditions. The scope of the method is highlighted in >40 examples
    报道了一种通过Weinreb酰胺(N-甲氧基-N-甲基酰胺)与功能化格氏试剂的芳基化反应,化学选择性合成联芳基酮的高效方法。在操作简单和实际的反应条件下,与i-PrMgCl·LiCl交换Mg /卤化物后,该方案可快速进入官能化的联芳基酮。在40多个实例中突出了该方法的范围,包括生物活性化合物和药物衍生物。总的来说,这种无过渡金属的方法相对于最近通过氧化加成NC(O)键实现的酰胺交叉偶联具有重要优势。考虑到酰胺酰化反应在现代合成中的实用性,我们预计该方法将引起广泛关注。
  • Cyclobutene derivatives
    申请人:Sankyo Company Limited
    公开号:EP1070703A1
    公开(公告)日:2001-01-24
    Compounds of formula (I): in which: R1 and R2 each represents a variety of organic groups; R3 and R4 each represents hydrogen or a variety of organic groups; A represents a group of formula (A-1):    [in which: R5 represents hydrogen, hydroxy or alkyl, R6 represents hydroxy, alkoxy, alkylthio or an amine residue, X and Y each represents oxygen or sulphur, and Z represents a direct single bond between the nitrogen atom shown and the benzene ring shown in formula (I), or an alkylene group], G represents a single bond, alkylene or substituted alkylene; the broken line represents a single or double bond; when the broken line represents a double bond, D represents a carbon atom; and E represents an =N-O- group; when the broken line represents a single bond, D represents a CH group or a nitrogen atom, and E represents an oxygen atom, a sulphur atom, an -NH- group or a -CO- group}; and pharmaceutically acceptable salts, esters or other derivatives thereof have the ability to inhibit an ileal bile transporter and so may be used to treat or prevent hypercholesterolaemia.
    式(I)化合物: 其中R1 和 R2 各自代表各种有机基团;R3 和 R4 各自代表氢或各种有机基团;A 代表式(A-1)的基团: 其中R5代表氢、羟基或烷基,R6代表羟基、烷氧基、烷硫基或胺残基,X和Y各自代表氧或硫,Z代表式(I)所示的氮原子和苯环之间的直接单键或亚烷基]、 G 代表单键、亚烷基或取代亚烷基;断线代表单键或双键;当断线代表双键时,D 代表碳原子;E 代表 =N-O- 基团;当断线代表单键时,D代表CH基团或氮原子,E代表氧原子、硫原子、-NH-基团或-CO-基团};其药学上可接受的盐、酯或其他衍生物具有抑制回肠胆汁转运体的能力,因此可用于治疗或预防高胆固醇血症。
  • 二苯甲酮类化合物及其制备方法和应用
    申请人:山东大学
    公开号:CN115611805A
    公开(公告)日:2023-01-17
    本申请提供了一种二苯甲酮类化合物或其药学上可接受的盐,其结构如式I所示: 其中,X为‑(C=O)‑NH‑或‑NH‑(C=O)‑;n为1‑10的整数;R1、R2、R3分别表示一个或多个取代基,多个取代基可相同或不同,R1、R2、R3各自独立地选自氢、卤素、C1‑5烷基、C1‑5烷氧基、羟基、硝基、氰基和氨基中的一个或多个。本发明的化合物能够调控Kv11.1通道,恢复或逆转阿司咪唑对Kv11.1通道的抑制作用,降低阿司咪唑的心脏毒性以及具有缓解获得性LQTS的药学活性,是治疗获得性LQTS的潜在药物。
  • (Phenylmethoxy)phenyl derivatives of w-oxo- and w-tetrazolylalkanoic acids and related tetrazoles. Synthesis and evaluation as leukotriene D4 receptor antagonists
    作者:Robert D. Dillard、Richard A. Hahn、Doris McCullough、F. Patrick Carr、Lynn E. Rinkema、Carlos R. Roman、Jerome H. Fleisch
    DOI:10.1021/jm00113a014
    日期:1991.9
    Two series of (phenylmethoxy)phenyl compounds derived from the structure of LY163443 were synthesized and evaluated as leukotriene D4 receptor antagonists. In the OMEGA-[(phenylmethoxy)phenyl]-OMEGA-oxoalkanoic acid series, 5-[4-[(4-acetyl-2-ethyl-3-hydroxyphenyl)methoxy]phenyl]-3,3-dimethyl-5-oxopentanoic acid (8) was the most potent antagonist of LTD4-induced contractions of guinea pig ileum (pK(B) of 7.60) and LTD4 pressor response in pithed rats (ED50 of 1.4 mg/kg iv). Replacing the carboxylic acid function with 5-tetrazole gave slightly more potent compounds. In the OMEGA-[5-[[(phenylmethoxy)phenyl]alkyl]tetrazolyl]alkanoic acid series, replacing the carboxylic acid with 5-tetrazole gave compounds that were equally effective in the guinea pig ileum but more potent in vivo against the LTD4 pressor response in rat. The pK(B) value in the guinea pig ileum for 1-[2-hydroxy-3-propyl-4-[[4-[[2-[3-(1H-tetrazol-5-yl)propyl]-2H-tetrazol-5-yl]methyl]phenoxy]methyl]phenyl]ethanone (25) was 7.87 and the ED50 for antagonism of the LTD4 pressor response was 4.0 mg/kg iv. The sodium salts of 8 (9) and 25 (26) given by the iv route of administration antagonized LTD4-induced cardiovascular alterations in anesthetized rat and LTD4-induced bronchoconstriction in guinea pig in a dose-dependent manner. Oral activity was also demonstrated against the LTD4-induced bronchoconstriction in guinea pig.
  • Wagner; Voigt, Pharmazie, 1976, vol. 31, # 6, p. 354 - 360
    作者:Wagner、Voigt
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐